Substance or medication-induced depressive disorder: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{KS}}
{{CMG}} {{AE}} {{KS}}
==Overview==
==Overview==


==Differential Diagnosis==
==Differential Diagnosis==
Line 10: Line 8:
*Primary [[depressive disorder]]
*Primary [[depressive disorder]]
*Substance intoxication and withdrawal<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>
*Substance intoxication and withdrawal<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 35: Line 31:
'''''AND'''''
'''''AND'''''


*B.There is evidence from the history, physical examination, or laboratory findings of both
*B.There is evidence from the history, physical examination, or laboratory findings of both (1)and(2):
(1)and(2):


:*1.The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
:*1.The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
:*2.The involved substance/medication is capable of producing the symptoms in Criterion A.
:*2.The involved substance/medication is capable of producing the symptoms in Criterion A.
:*C.The disturbance is not better explained by a depressive disorder that is not substance/medication-induced. Such evidence of an independent [[depressive disorder]] could include the following:


The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute
'''''AND'''''
 
*C.The disturbance is not better explained by a [[depressive disorder]] that is not substance/medication-induced. Such evidence of an independent [[depressive disorder]] could include the following:
 
:*The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute
withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication-related episodes).
withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication-related episodes).



Revision as of 18:08, 10 November 2014

WikiDoc Resources for Substance or medication-induced depressive disorder

Articles

Most recent articles on Substance or medication-induced depressive disorder

Most cited articles on Substance or medication-induced depressive disorder

Review articles on Substance or medication-induced depressive disorder

Articles on Substance or medication-induced depressive disorder in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Substance or medication-induced depressive disorder

Images of Substance or medication-induced depressive disorder

Photos of Substance or medication-induced depressive disorder

Podcasts & MP3s on Substance or medication-induced depressive disorder

Videos on Substance or medication-induced depressive disorder

Evidence Based Medicine

Cochrane Collaboration on Substance or medication-induced depressive disorder

Bandolier on Substance or medication-induced depressive disorder

TRIP on Substance or medication-induced depressive disorder

Clinical Trials

Ongoing Trials on Substance or medication-induced depressive disorder at Clinical Trials.gov

Trial results on Substance or medication-induced depressive disorder

Clinical Trials on Substance or medication-induced depressive disorder at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Substance or medication-induced depressive disorder

NICE Guidance on Substance or medication-induced depressive disorder

NHS PRODIGY Guidance

FDA on Substance or medication-induced depressive disorder

CDC on Substance or medication-induced depressive disorder

Books

Books on Substance or medication-induced depressive disorder

News

Substance or medication-induced depressive disorder in the news

Be alerted to news on Substance or medication-induced depressive disorder

News trends on Substance or medication-induced depressive disorder

Commentary

Blogs on Substance or medication-induced depressive disorder

Definitions

Definitions of Substance or medication-induced depressive disorder

Patient Resources / Community

Patient resources on Substance or medication-induced depressive disorder

Discussion groups on Substance or medication-induced depressive disorder

Patient Handouts on Substance or medication-induced depressive disorder

Directions to Hospitals Treating Substance or medication-induced depressive disorder

Risk calculators and risk factors for Substance or medication-induced depressive disorder

Healthcare Provider Resources

Symptoms of Substance or medication-induced depressive disorder

Causes & Risk Factors for Substance or medication-induced depressive disorder

Diagnostic studies for Substance or medication-induced depressive disorder

Treatment of Substance or medication-induced depressive disorder

Continuing Medical Education (CME)

CME Programs on Substance or medication-induced depressive disorder

International

Substance or medication-induced depressive disorder en Espanol

Substance or medication-induced depressive disorder en Francais

Business

Substance or medication-induced depressive disorder in the Marketplace

Patents on Substance or medication-induced depressive disorder

Experimental / Informatics

List of terms related to Substance or medication-induced depressive disorder

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Differential Diagnosis

Epidemiology and Demographics

Prevalence

The prevalence of substance or medication-induced depressive disorder is 260 per 100,000 (0.26%) of the overall population.[1]

Risk Factors

Diagnostic Criteria

DSM-V Diagnostic Criteria for Substance/Medication-Induced Depressive Disorder [1]

  • A.A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by depressed mood or markedly diminished interest or pleasure in all, or almost all, activities.

AND

  • B.There is evidence from the history, physical examination, or laboratory findings of both (1)and(2):
  • 1.The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
  • 2.The involved substance/medication is capable of producing the symptoms in Criterion A.

AND

  • The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute

withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication-related episodes).

AND

  • D.The disturbance does not occur exclusively during the course of a delirium.

AND

  • E.The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning.

Note:This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention. .

References

  1. 1.0 1.1 1.2 1.3 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.


Template:WikiDoc Sources